American Pharmaceutical Review
331 FOLLOWERS
Offers editorial coverage of the latest developments in drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing, and regulatory affairs. American Pharmaceutical Review is the leading review journal for business and technology in the pharmaceutical industry throughout North America.
American Pharmaceutical Review
1w ago
Charles River Laboratories International, Inc. announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with ..read more
American Pharmaceutical Review
1w ago
BrainStorm Cell Therapeutics Inc. , a developer of adult stem cell therapeutics for neurodegenerative diseases, announced that it received written ..read more
American Pharmaceutical Review
1w ago
Essential Pharma, a specialty pharma group has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd. Renaissance ..read more
American Pharmaceutical Review
1w ago
Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk under a framework agreement that initially is contemplated to ..read more
American Pharmaceutical Review
1w ago
FAonline INC is voluntarily recalling all lots within expiry of the ForeverMen capsules to the consumer level. FDA analysis founds these products to ..read more
American Pharmaceutical Review
2w ago
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. and mAbxience, a Fresenius Kabi majority-owned group with ..read more
American Pharmaceutical Review
2w ago
Caris Discovery™, the therapeutic research arm of Caris Life Sciences® (Caris), announced a multi-year strategic partnership with Merck KGaA ..read more
American Pharmaceutical Review
2w ago
Ligand Pharmaceuticals announced the launch of Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and the appointment of seasoned industry ..read more
American Pharmaceutical Review
2w ago
ARCA biopharma, Inc. and Oruka Therapeutics announced that they have entered into a definitive agreement to combine the companies in an all-stock ..read more
American Pharmaceutical Review
2w ago
dsm-firmenich, has announced a new strategic collaboration with Oz Medicann Group (OMG) Pharma – an Australian-based biotech innovator in the ..read more